SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HMSC- A simple breast cancer screening device

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dante Sinferno who wrote (196)5/7/1998 7:56:00 AM
From: FCC  Read Replies (4) of 246
 
Robert,
I'm sure that labeling objections are a common problem with the FDA.
It seems to me that a company's advertising dept. will try to get away with whatever they can. Here's the company's reply,
According to Donald Brounstein, President and Chief Executive Officer of HumaScan, the Company is in the process of revising its labeling and advertising materials and is preparing a response. The Company does not expect the changes sought by the FDA to have a significant effect on the Company.

The main make or break point for this HMSC IMHO, is the clinical trials results, which are due 6-8 weeks. There is a breast cancer meeting sometime this month. This will give a lot of exposure to product. Does anyone know when conference will begin?

You are correct I feel when you say that this company's future will be apparent in the future. My guess is about 3-4 months. BTW, I have bought again at these levels.

Regards,

FCC

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext